January 6, 2014

Nail care brand Nicole by OPI and Dove Dark Chocolate are ringing in the New Year with the launch of the "Discover Your Dark Side in the New Year Sweepstakes."

January 2, 2014

Drug maker Eisai will make a new epilepsy drug available in the United States starting on Monday, the company said.

December 30, 2013

Drug maker Merck is starting a new business designed to provide weight-management intervention services to employers, patients and healthcare professionals, the company said.

December 26, 2013

Thanks in part to the launch of Alka-Seltzer Fruit Chews, the Alka-Seltzer brand has experienced a resurgence within the antacid tablet category.

December 26, 2013

Mars will launch a new M&M flavor in May, M&M’s Brand Birthday Cake Chocolate Candies.

December 26, 2013

Actavis last year gained approval for its Next Choice, a generic version of Teva Women’s Health’s Plan B One-Step, that now sits on top in emergency contraceptive sales.

December 26, 2013

Church & Dwight’s new Trojan lubricant line has achieved a 7% share of the lubricant category almost straight out of the gate, James Craigie, C&D executive chairman, CEO and interim president of the company’s domestic personal care division, told analysts.

December 23, 2013

A federal court decision paves the way for Amneal Pharmaceuticals and its South Korean partnering company to market a drug for treating gastroesophageal reflux disease, the companies said Monday.

December 17, 2013

Amneal Pharmaceuticals has launched a new treatment for gastroesophageal reflux disease under a partnership with a South Korean drug maker.

December 17, 2013

Greenstone has launched a version of a drug used to treat fungal infections, the company said.

December 16, 2013

Everett Labs has acquired Quinnova Pharmaceuticals from Amneal Enterprises, Everett said Monday.

December 13, 2013

A newly appointed executive at Campbell Soup will be responsible for establishing the company's strategic direction for advertising, media, global design, digital marketing and social media.

December 12, 2013

Unilever’s men’s grooming brand, Axe, made history last year during Super Bowl XLVII after announcing plans to send one viewer to space as part of its Apollo campaign. This year, Axe returns to the big game to air a 30-second television commercial.

December 12, 2013

A panel of experts at the Food and Drug Administration has recommended approval for an experimental biotech drug under development by Bristol-Myers Squibb and AstraZeneca for a group of rare metabolic disorders.

December 12, 2013

Dog owners have two new reasons to rejoice this holiday season, thanks to Freshpet.

December 12, 2013

Vitamin Shoppe announced that the company had filed suit against law firm Seeger Weiss in New York federal court.

December 10, 2013

The natural personal care market continues to see strong growth, posting healthy double-digit gains globally with Brazil and China taking the lead as the fastest-growing natural personal care markets, according to consulting and research firm Kline & Co.

December 5, 2013

Arm & Hammer Oral Care has teamed up with actress Alison Sweeney, who will appear in the brand's advertising, public relations and digital media campaigns.

December 5, 2013

Church & Dwight announced plans to expand its gummy vitamin production capacity through the addition of a new production line to be constructed at its manufacturing facility in Pennsylvania.

December 3, 2013

Inergetics and the Podiatree Co. on Tuesday launched Intrinsix, a podiatry-exclusive nerve health support supplement enriched with calcium and vitamin D.

December 3, 2013

Mars is introducing a flurry of new chocolate treats for the holiday season to accompany its traditional festive offerings.

November 26, 2013

The Food and Drug Administration has approved a new tablet form of an antifungal drug made by Merck, the company said Tuesday.

November 26, 2013

QRxPharma has resubmitted its regulatory approval application for an opioid painkiller for which it has sought Food and Drug Administration approval since 2011, the company said Tuesday.

November 25, 2013

The Food and Drug Administration has approved a new treatment made by Johnson & Johnson for hepatitis C, the drug maker said.